시장보고서
상품코드
1895335

주입 펌프 소프트웨어 시장 인사이트, 경쟁 구도 및 시장 예측(-2033년)

Infusion Pump Software Market Insights, Competitive Landscape, and Market Forecast - 2033

발행일: | 리서치사: Fairfield Market Research | 페이지 정보: 영문 200 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 주입 펌프 소프트웨어 시장은 의료 서비스 프로바이더들이 환자 안전과 약물 투여 효율화를 위해 첨단 디지털 솔루션을 도입하는 움직임이 가속화되면서 꾸준한 성장세를 보이고 있습니다. 주입 펌프 소프트웨어는 약물의 정확한 투여를 가능하게 하고, 실수를 줄이며, 임상 워크플로우를 개선하는 현대 의료의 중요한 구성 요소입니다. 시장 규모는 2026년까지 18억 달러에 달하며, 2033년까지 30억 달러로 성장할 것으로 예측되고 있으며, 예측 기간 중 CAGR은 8%를 기록할 전망입니다.

시장 인사이트

주입 펌프 소프트웨어는 투약 오류 감소, 전자건강기록(EHR)과의 상호운용성, 워크플로우 최적화 등 주요 기능을 통합하고 있습니다. 이러한 기능으로 인해 병원, 외래진료센터, 재택의료, 연구시설에서 도입이 진행되고 있습니다. 당뇨병, 암, 심혈관 질환 등 만성질환이 증가함에 따라 정확하고 자동화된 수액 주입 시스템에 대한 수요가 증가하고 있습니다. 환자 안전을 중시하는 규제 프레임워크도 시장 성장을 가속하고 있으며, 주입 펌프 소프트웨어는 전 세계 의료시설에 필수적인 툴이 되고 있습니다.

성장 촉진요인

시장의 주요 촉진요인은 보다 안전하고 효율적인 약물 투여의 필요성입니다. 투약 오류 감소 소프트웨어(DERS)는 과량 및 과소 투여를 방지하여 환자의 안전성을 크게 향상시킵니다. 상호운용성 소프트웨어는 병원의 IT 시스템과의 원활한 통합을 통해 실시간 모니터링과 임상적 판단을 향상시킬 수 있습니다. 또한 재택치료 서비스 및 외래 진료 증가는 원격 모니터링 및 환자 관리를 지원하는 소프트웨어 솔루션의 기회를 창출하고 수액 소프트웨어의 적용 범위를 확장하고 있습니다.

비즈니스 기회

의료 인프라가 빠르게 확장되고 있는 신흥 시장에는 큰 성장 기회가 존재합니다. 아시아태평양, 라틴아메리카, 중동 및 아프리카 등의 지역에서는 기술 기반 의료 솔루션에 대한 투자가 증가하고 있습니다. 주입 펌프 제조업체와 소프트웨어 프로바이더가 협력하여 효율성, 안전성, 환자 결과를 개선하는 통합 시스템 개발이 진행되고 있습니다. 화학요법, 인슐린 주입, 통증 관리 등 치료 분야에 특화된 소프트웨어에 집중하는 기업은 시장 점유율을 확보할 수 있는 좋은 위치에 있습니다.

지역별 분석

북미는 높은 의료비 지출, 첨단화된 인프라, 디지털 헬스 기술의 보급으로 인해 주입 펌프 소프트웨어 시장을 주도하고 있습니다. 유럽은 엄격한 규제와 환자 안전에 대한 집중적인 노력을 바탕으로 북미에 이어 두 번째로 성장할 것으로 예측됩니다. 아시아태평양은 의료 현대화, 만성질환 유병률 증가, 재택의료 서비스 수요 증가로 인해 고성장 지역이 될 것으로 예측됩니다. 라틴아메리카와 중동 및 아프리카은 정부가 의료 접근성 개선과 기술 기반 솔루션 도입에 투자하고 있으며, 꾸준한 성장이 예상됩니다.

주요 기업

세계의 주입 펌프 소프트웨어 시장은 경쟁이 치열하고, 주요 기업은 혁신과 전략적 제휴에 주력하고 있습니다. 주요 기업은 다음과 같습니다. :

  • Becton, Dickinson and Company(BD)
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • ICU Medical, Inc.
  • Medtronic plc
  • Smiths Medical
  • Fresenius Kabi AG
  • Terumo Corporation
  • Moog Inc.
  • Mindray Medical International Limited
  • Zyno Medical LLC
  • Ypsomed Holding AG
  • Micrel Medical Devices S.A.
  • Nipro Corporation
  • Insulet Corporation

세분화

유형별:

  • 투약 오류 감소 소프트웨어(DERS)
  • 상호운용성 소프트웨어
  • 임상 워크플로우 소프트웨어

적응증별:

  • 일반 수액
  • 통증 및 마취 관리
  • 인슐린 주입
  • 화학요법
  • 경장영양

최종사용자별:

  • 병원
  • 외래진료시설
  • 재택의료시설
  • 학술-연구기관

지역별:

  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

목차

제1장 개요

  • 세계의 주입 펌프 소프트웨어 시장 스냅숏
  • 향후 예측
  • 주요 시장 동향
  • 지역별 스냅숏(금액별, 2026년)
  • 애널리스트의 권장사항

제2장 시장 개요

  • 시장 정의와 세분화
  • 시장 역학
  • 밸류체인 분석
  • COVID-19의 영향 분석
  • Porter's Five Forces 분석
  • 러시아·우크라이나 분쟁의 영향
  • PESTLE 분석
  • 규제 분석
  • 가격 동향 분석

제3장 세계의 주입 펌프 소프트웨어 시장 전망, 2020-2033년

  • 세계의 주입 펌프 소프트웨어 시장 전망, 유형별, 금액(10억 달러), 2020-2033년
    • 선량 오차 저감 소프트웨어(DERS)
    • 상호운용성 소프트웨어
    • 임상 워크플로우 소프트웨어
  • 세계의 주입 펌프 소프트웨어 시장 전망, 적응증별, 금액(10억 달러), 2020-2033년
    • 일반 수액
    • 통증과 마취 관리
    • 인슐린 주입
    • 화학요법
    • 경장주입
  • 세계의 주입 펌프 소프트웨어 시장 전망, 최종사용자별, 금액(10억 달러), 2020-2033년
    • 병원
    • 외래 센터 설정
    • 재택 의료 환경
    • 학술 조사기관
  • 세계의 주입 펌프 소프트웨어 시장 전망, 지역별, 금액(10억 달러), 2020-2033년
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카

제4장 북미의 주입 펌프 소프트웨어 시장 전망, 2020-2033년

제5장 유럽의 주입 펌프 소프트웨어 시장 전망, 2020-2033년

제6장 아시아태평양의 주입 펌프 소프트웨어 시장 전망, 2020-2033년

제7장 라틴아메리카 주입 펌프 소프트웨어 시장 전망, 2020-2033년

제8장 중동 및 아프리카의 주입 펌프 소프트웨어 시장 전망, 2020-2033년

제9장 경쟁 구도

  • 기업 대 부문 히트맵
  • 기업 시장 점유율 분석, 2025년
  • 경쟁 대시보드
  • 기업 개요
    • Becton, Dickinson and Company(BD)
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • ICU Medical, Inc.
    • Medtronic plc
    • Smiths Medical
    • Fresenius Kabi AG
    • Terumo Corporation
    • Moog Inc.
    • Mindray Medical International Limited

제10장 부록

KSA 26.01.07

The global infusion pump software market is witnessing steady growth as healthcare providers increasingly adopt advanced digital solutions to enhance patient safety and streamline medication delivery. Infusion pump software is a vital component in modern healthcare, enabling precise administration of drugs, reducing errors, and improving clinical workflows. The market is projected to reach USD 1.8 billion by 2026 and is expected to grow to USD 3 billion by 2033, registering a CAGR of 8% over the forecast period.

Market Insights

Infusion pump software integrates key functionalities such as dose error reduction, interoperability with electronic health records (EHRs), and workflow optimization. These capabilities are driving adoption in hospitals, ambulatory centers, home healthcare, and research settings. With chronic diseases such as diabetes, cancer, and cardiovascular conditions on the rise, the demand for accurate and automated infusion systems is increasing. Regulatory frameworks emphasizing patient safety further support market growth, making infusion pump software an essential tool for healthcare facilities worldwide.

Drivers

A primary factor driving the market is the need for safer and more efficient medication administration. Dose Error Reduction Software (DERS) prevents over- or under-dosing, significantly improving patient safety. Interoperability software allows seamless integration with hospital IT systems, enabling real-time monitoring and better clinical decision-making. Additionally, the rise in home-based healthcare services and outpatient care is creating opportunities for software solutions that facilitate remote monitoring and patient management, expanding the scope of infusion software applications.

Business Opportunity

Significant growth opportunities exist in emerging markets where healthcare infrastructure is rapidly expanding. Regions such as Asia Pacific, Latin America, and the Middle East & Africa are witnessing increased investments in technology-driven healthcare solutions. Collaborations between infusion pump manufacturers and software providers are enabling the development of integrated systems that improve efficiency, safety, and patient outcomes. Companies that focus on specialized software for therapeutic areas such as chemotherapy, insulin infusion, and pain management are well-positioned to capture market share.

Region Analysis

North America dominates the infusion pump software market due to high healthcare expenditure, advanced infrastructure, and widespread adoption of digital health technologies. Europe follows closely, supported by strict regulations and a focus on patient safety. Asia Pacific is expected to be a high-growth region, driven by increasing healthcare modernization, rising prevalence of chronic illnesses, and growing demand for home healthcare services. Latin America and the Middle East & Africa are projected to show steady growth as governments invest in improving healthcare access and adopting technology-enabled solutions.

Key Players

The global infusion pump software market is highly competitive, with leading companies focusing on innovation and strategic partnerships. Key players include:

  • Becton, Dickinson and Company (BD)
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • ICU Medical, Inc.
  • Medtronic plc
  • Smiths Medical
  • Fresenius Kabi AG
  • Terumo Corporation
  • Moog Inc.
  • Mindray Medical International Limited
  • Zyno Medical LLC
  • Ypsomed Holding AG
  • Micrel Medical Devices S.A.
  • Nipro Corporation
  • Insulet Corporation

Segmentation

By Type:

  • Dose Error Reduction Software (DERS)
  • Interoperability Software
  • Clinical Workflow Software

By Indication:

  • General Infusion
  • Pain and Anesthesia Management
  • Insulin Infusion
  • Chemotherapy
  • Enteral Infusion

By End User:

  • Hospitals
  • Ambulatory Centers Settings
  • Home Healthcare Settings
  • Academic & Research Institutes

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Table of Contents

"1. Executive Summary

  • 1.1. Global Infusion Pump Software Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations
  • 2. Market Overview
  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Fiver Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors
  • 3. Global Infusion Pump Software Market Outlook, 2020 - 2033
  • 3.1. Global Infusion Pump Software Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 3.1.1. Dose Error Reduction Software (DERS)
    • 3.1.2. Interoperability Software
    • 3.1.3. Clinical Workflow Software
  • 3.2. Global Infusion Pump Software Market Outlook, by Indication, Value (US$ Bn), 2020-2033
    • 3.2.1. General Infusion
    • 3.2.2. Pain and Anesthesia Management
    • 3.2.3. Insulin Infusion
    • 3.2.4. Chemotherapy
    • 3.2.5. Enteral Infusion
  • 3.3. Global Infusion Pump Software Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 3.3.1. Hospitals
    • 3.3.2. Ambulatory Centers Settings
    • 3.3.3. Home Healthcare Settings
    • 3.3.4. Academic & Research Institutes
  • 3.4. Global Infusion Pump Software Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa
  • 4. North America Infusion Pump Software Market Outlook, 2020 - 2033
  • 4.1. North America Infusion Pump Software Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 4.1.1. Dose Error Reduction Software (DERS)
    • 4.1.2. Interoperability Software
    • 4.1.3. Clinical Workflow Software
  • 4.2. North America Infusion Pump Software Market Outlook, by Indication, Value (US$ Bn), 2020-2033
    • 4.2.1. General Infusion
    • 4.2.2. Pain and Anesthesia Management
    • 4.2.3. Insulin Infusion
    • 4.2.4. Chemotherapy
    • 4.2.5. Enteral Infusion
  • 4.3. North America Infusion Pump Software Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 4.3.1. Hospitals
    • 4.3.2. Ambulatory Centers Settings
    • 4.3.3. Home Healthcare Settings
    • 4.3.4. Academic & Research Institutes
  • 4.4. North America Infusion Pump Software Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 4.4.2. U.S. Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 4.4.3. U.S. Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 4.4.4. Canada Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 4.4.5. Canada Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 4.4.6. Canada Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis
  • 5. Europe Infusion Pump Software Market Outlook, 2020 - 2033
  • 5.1. Europe Infusion Pump Software Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 5.1.1. Dose Error Reduction Software (DERS)
    • 5.1.2. Interoperability Software
    • 5.1.3. Clinical Workflow Software
  • 5.2. Europe Infusion Pump Software Market Outlook, by Indication, Value (US$ Bn), 2020-2033
    • 5.2.1. General Infusion
    • 5.2.2. Pain and Anesthesia Management
    • 5.2.3. Insulin Infusion
    • 5.2.4. Chemotherapy
    • 5.2.5. Enteral Infusion
  • 5.3. Europe Infusion Pump Software Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 5.3.1. Hospitals
    • 5.3.2. Ambulatory Centers Settings
    • 5.3.3. Home Healthcare Settings
    • 5.3.4. Academic & Research Institutes
  • 5.4. Europe Infusion Pump Software Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 5.4.2. Germany Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 5.4.3. Germany Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 5.4.4. Italy Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 5.4.5. Italy Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 5.4.6. Italy Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 5.4.7. France Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 5.4.8. France Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 5.4.9. France Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 5.4.10. U.K. Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 5.4.11. U.K. Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 5.4.12. U.K. Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 5.4.13. Spain Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 5.4.14. Spain Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 5.4.15. Spain Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 5.4.16. Russia Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 5.4.17. Russia Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 5.4.18. Russia Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 5.4.19. Rest of Europe Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 5.4.20. Rest of Europe Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 5.4.21. Rest of Europe Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis
  • 6. Asia Pacific Infusion Pump Software Market Outlook, 2020 - 2033
  • 6.1. Asia Pacific Infusion Pump Software Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 6.1.1. Dose Error Reduction Software (DERS)
    • 6.1.2. Interoperability Software
    • 6.1.3. Clinical Workflow Software
  • 6.2. Asia Pacific Infusion Pump Software Market Outlook, by Indication, Value (US$ Bn), 2020-2033
    • 6.2.1. General Infusion
    • 6.2.2. Pain and Anesthesia Management
    • 6.2.3. Insulin Infusion
    • 6.2.4. Chemotherapy
    • 6.2.5. Enteral Infusion
  • 6.3. Asia Pacific Infusion Pump Software Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 6.3.1. Hospitals
    • 6.3.2. Ambulatory Centers Settings
    • 6.3.3. Home Healthcare Settings
    • 6.3.4. Academic & Research Institutes
  • 6.4. Asia Pacific Infusion Pump Software Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 6.4.2. China Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 6.4.3. China Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 6.4.4. Japan Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 6.4.5. Japan Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 6.4.6. Japan Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 6.4.7. South Korea Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 6.4.8. South Korea Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 6.4.9. South Korea Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 6.4.10. India Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 6.4.11. India Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 6.4.12. India Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 6.4.13. Southeast Asia Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 6.4.14. Southeast Asia Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 6.4.15. Southeast Asia Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 6.4.16. Rest of SAO Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 6.4.17. Rest of SAO Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 6.4.18. Rest of SAO Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis
  • 7. Latin America Infusion Pump Software Market Outlook, 2020 - 2033
  • 7.1. Latin America Infusion Pump Software Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 7.1.1. Dose Error Reduction Software (DERS)
    • 7.1.2. Interoperability Software
    • 7.1.3. Clinical Workflow Software
  • 7.2. Latin America Infusion Pump Software Market Outlook, by Indication, Value (US$ Bn), 2020-2033
    • 7.2.1. General Infusion
    • 7.2.2. Pain and Anesthesia Management
    • 7.2.3. Insulin Infusion
    • 7.2.4. Chemotherapy
    • 7.2.5. Enteral Infusion
  • 7.3. Latin America Infusion Pump Software Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Centers Settings
    • 7.3.3. Home Healthcare Settings
    • 7.3.4. Academic & Research Institutes
  • 7.4. Latin America Infusion Pump Software Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 7.4.2. Brazil Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 7.4.3. Brazil Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 7.4.4. Mexico Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 7.4.5. Mexico Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 7.4.6. Mexico Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 7.4.7. Argentina Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 7.4.8. Argentina Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 7.4.9. Argentina Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 7.4.10. Rest of LATAM Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 7.4.11. Rest of LATAM Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 7.4.12. Rest of LATAM Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis
  • 8. Middle East & Africa Infusion Pump Software Market Outlook, 2020 - 2033
  • 8.1. Middle East & Africa Infusion Pump Software Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 8.1.1. Dose Error Reduction Software (DERS)
    • 8.1.2. Interoperability Software
    • 8.1.3. Clinical Workflow Software
  • 8.2. Middle East & Africa Infusion Pump Software Market Outlook, by Indication, Value (US$ Bn), 2020-2033
    • 8.2.1. General Infusion
    • 8.2.2. Pain and Anesthesia Management
    • 8.2.3. Insulin Infusion
    • 8.2.4. Chemotherapy
    • 8.2.5. Enteral Infusion
  • 8.3. Middle East & Africa Infusion Pump Software Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 8.3.1. Hospitals
    • 8.3.2. Ambulatory Centers Settings
    • 8.3.3. Home Healthcare Settings
    • 8.3.4. Academic & Research Institutes
  • 8.4. Middle East & Africa Infusion Pump Software Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 8.4.2. GCC Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 8.4.3. GCC Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 8.4.4. South Africa Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 8.4.5. South Africa Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 8.4.6. South Africa Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 8.4.7. Egypt Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 8.4.8. Egypt Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 8.4.9. Egypt Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 8.4.10. Nigeria Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 8.4.11. Nigeria Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 8.4.12. Nigeria Infusion Pump Software Market Outlook, by End User, 2020-2033
    • 8.4.13. Rest of Middle East Infusion Pump Software Market Outlook, by Type, 2020-2033
    • 8.4.14. Rest of Middle East Infusion Pump Software Market Outlook, by Indication, 2020-2033
    • 8.4.15. Rest of Middle East Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis
  • 9. Competitive Landscape
  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Becton, Dickinson and Company (BD)
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Baxter International Inc.
    • 9.4.3. B. Braun Melsungen AG
    • 9.4.4. ICU Medical, Inc.
    • 9.4.5. Medtronic plc
    • 9.4.6. Smiths Medical
    • 9.4.7. Fresenius Kabi AG
    • 9.4.8. Terumo Corporation
    • 9.4.9. Moog Inc.
    • 9.4.10. Mindray Medical International Limited

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations

"

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제